Sign in

CIK 0001723128 · Large accelerated filer

Amneal Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
Phone
(908) 947-3120
Former names
Atlas Holdings, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-03 Shah Nikita Executive Vice President Option exercise · Restricted Stock Units −36,232 36,232
2025-03-03 Shah Nikita Executive Vice President Option exercise · Restricted Stock Units −45,872 91,743
2025-03-03 Shah Nikita Executive Vice President Option exercise · Performance-Based Restricted Stock Units −144,928 0
2025-03-03 Shah Nikita Executive Vice President Grant or award · Performance-Based Restricted Stock Units +188,356 188,356
2025-03-03 Shah Nikita Executive Vice President Grant or award · Restricted Stock Units +94,178 94,178
2025-03-01 BOYER ANDREW S Executive Vice President Option exercise +31,371 288,041
2025-03-01 BOYER ANDREW S Executive Vice President Shares withheld for taxes −11,737 $8.67 $102K 276,304
2025-03-01 BOYER ANDREW S Executive Vice President Option exercise · Restricted Stock Units −31,371 0
2025-03-01 Konidaris Tasos Executive Vice President & CFO Option exercise +36,197 563,513
2025-03-01 Konidaris Tasos Executive Vice President & CFO Shares withheld for taxes −13,494 $8.67 $117K 550,019
2025-03-01 Konidaris Tasos Executive Vice President & CFO Option exercise · Restricted Stock Units −36,197 0
2025-03-01 Shah Nikita Executive Vice President Option exercise +28,958 320,624
2025-03-01 Shah Nikita Executive Vice President Shares withheld for taxes −10,985 $8.67 $95K 309,639
2025-03-01 Shah Nikita Executive Vice President Option exercise · Restricted Stock Units −28,958 0
2025-02-03 Patel Gautam Director Sale −80,000 $8.14 $651K 1,888,886
2025-01-08 Patel Gautam Director Sale 10b5-1 −62,590 $8.01 $501K 1,968,886
2025-01-02 Patel Gautam Director Sale 10b5-1 −17,410 $8.01 $139K 2,031,476
2024-11-22 Kiely John Director Option exercise +28,506 $4.76 $136K 284,233
2024-11-22 Kiely John Director Sale −17,058 $8.38 $143K 267,175
2024-11-22 Kiely John Director Option exercise · Stock Option −28,506 0

Page 14 of 31 · 617 trades